News
Important Only
Arthrosi Secures $153 Million In Series E Financing To Complete Pivotal Development Of Pozdeutinurad For The Treatment Of Gout And Tophaceous Gout
Oct 8 (Reuters) - ARTHROSI SECURES $153 MILLION IN SERIES E FINANCING TO COMPLETE PIVOTAL DEVELOPMENT OF POZDEUTINURAD FOR THE TREATMENT OF GOUT AND TOPHACEOUS GOUTARTHROSI THERAPEUTICS : FINANCING LED BY PRIME EIGHT CAPITAL LIMITED, PARTICIPATION FROM CR BIOTECH,HIGHLIGHT CAPITAL, OTHERSFurther com...Reuters
Wed, Oct 8
Boehringer Ingelheim Obtains Novel Preclinical Oncology Program From Accent Therapeutics
Oct 8 (Reuters) - BOEHRINGER INGELHEIM OBTAINS NOVEL PRECLINICAL ONCOLOGY PROGRAM FROM ACCENT THERAPEUTICSBOEHRINGER INGELHEIM: ACCENT THERAPEUTICS TO GET UPFRONT PAYMENT AND ENTITLED TO SUCCESS-BASED PRECLINICAL MILESTONE PAYMENTSFurther company coverage: [ ]Reuters
Wed, Oct 8
H.B. Fuller Further Strengthens Board With Appointment Of Medtech Leader Celine Martin To Support Growth In Medical Market
Oct 8 (Reuters) - H.B. Fuller Company FUL.N:H.B. FULLER FURTHER STRENGTHENS BOARD WITH APPOINTMENT OF MEDTECH LEADER CELINE MARTIN TO SUPPORT GROWTH IN MEDICAL MARKETReuters
Wed, Oct 8
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
Oct 8 (Reuters) - Astria Therapeutics Inc ATXS.O:ASTRIA THERAPEUTICS INITIATES THE PHASE 3 ORBIT-EXPANSE LONG-TERM TRIAL OF NAVENIBART IN PEOPLE WITH HEREDITARY ANGIOEDEMAReuters
Wed, Oct 8
Diversified Healthcare Trust Provides Update On 116 Alerislife Management Agreements Transitioning To New Operators
Oct 8 (Reuters) - Diversified Healthcare Trust DHC.O:DIVERSIFIED HEALTHCARE TRUST PROVIDES UPDATE REGARDING THE 116 ALERISLIFE MANAGEMENT AGREEMENTS TRANSITIONING TO NEW OPERATORSDIVERSIFIED HEALTHCARE TRUST - EXPECTS PROCEEDS OF $25 MILLION-$40 MILLION FOR ITS 34% INTEREST IN ALERISLIFEReuters
Wed, Oct 8
